Mono Vaccine Market to Grow by USD 2.8 Bn, Meningococcal Vac

/PRNewswire/ -- The mono-vaccine market is expected to grow by USD 2.8 billion from 2021 to 2026. In addition, the growth momentum of the market will...

Related Keywords

China , Germany , Japan , United States , India , United Kingdom , France , Japanese , America , Jesse Maida , Age Group , Aurobindo Pharma Ltd , Glaxosmithkline Plc , Dynavax Technologies Corp , Technavio Research , Product Service , Vaccines Inc , Astrazeneca Plc , China National Biotec Group , China National Pharmaceutical Group Corp , Serum Institute Of India Pvt , Pfizer Inc , Moderna Inc , Shenzhen Kangtai Biological Products Co , Vaccine Market , Meningococcal Vaccine , North America , Mono Vaccine Market , Bavarian Nordic , Serum Institute , Shenzhen Kangtai Biological Products , Kangtai Biological Products , Zeneca Plc , China National Biotec , Vaccines Market , Disease Type , Toxoid Vaccine Market , Executive Summary , Data Table , Global Market , Market Segmentation , Vendor Market , Encephalitis Vaccine , Japanese Encephalitis Vaccine , Hepatitis Vaccine , Fever Vaccine , Yellow Fever Vaccine , National Pharmaceutical Group , China National Pharmaceutical Group , Dynavax Technologies , Technavio ,